Galapagos is committed to finding novel and effective drugs to treat bone and joint diseases, bone metastasis, cachexia, and infectious and metabolic diseases. It has a strong team of first-class researchers that drive the innovative approach to identification of novel drug targets and the development of candidate drugs. Galapagos has a strong investor base, with a long term commitment to the biotech industry. Whether you are a current investor in Galapagos or are evaluating Galapagos as a potential investment opportunity, we hope you find this section of the website informative. The documents below provide a brief introduction to Galapagos. To receive an investor pack (available in English or Dutch), please contact the Investor Relations team.

Corporate Fact Sheet (English)

Corporate Fact Sheet (Dutch)

Company Presentation